Steward Partners Investment Advisory’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $74.7K | Buy |
2,707
+92
| +4% | +$2.54K | ﹤0.01% | 2272 |
|
2025
Q1 | $74.1K | Sell |
2,615
-547
| -17% | -$15.5K | ﹤0.01% | 2190 |
|
2024
Q4 | $131K | Sell |
3,162
-1,584
| -33% | -$65.9K | ﹤0.01% | 1838 |
|
2024
Q3 | $317K | Sell |
4,746
-377
| -7% | -$25.2K | ﹤0.01% | 1305 |
|
2024
Q2 | $608K | Sell |
5,123
-1,310
| -20% | -$156K | 0.01% | 981 |
|
2024
Q1 | $686K | Sell |
6,433
-62
| -1% | -$6.61K | 0.01% | 928 |
|
2023
Q4 | $646K | Buy |
6,495
+1,258
| +24% | +$125K | 0.01% | 883 |
|
2023
Q3 | $541K | Buy |
5,237
+586
| +13% | +$60.5K | 0.01% | 895 |
|
2023
Q2 | $565K | Sell |
4,651
-1,157
| -20% | -$141K | 0.01% | 895 |
|
2023
Q1 | $892K | Sell |
5,808
-155
| -3% | -$23.8K | 0.01% | 736 |
|
2022
Q4 | $1.07M | Sell |
5,963
-293
| -5% | -$52.6K | 0.02% | 640 |
|
2022
Q3 | $740K | Sell |
6,256
-400
| -6% | -$47.3K | 0.01% | 727 |
|
2022
Q2 | $951K | Sell |
6,656
-152
| -2% | -$21.7K | 0.02% | 644 |
|
2022
Q1 | $1.17M | Sell |
6,808
-9,682
| -59% | -$1.67M | 0.02% | 643 |
|
2021
Q4 | $4.19M | Sell |
16,490
-17,799
| -52% | -$4.52M | 0.06% | 302 |
|
2021
Q3 | $13.2M | Buy |
34,289
+2,419
| +8% | +$931K | 0.23% | 101 |
|
2021
Q2 | $7.49M | Buy |
31,870
+24,439
| +329% | +$5.74M | 0.13% | 173 |
|
2021
Q1 | $973K | Buy |
7,431
+4,362
| +142% | +$571K | 0.02% | 659 |
|
2020
Q4 | $321K | Sell |
3,069
-156
| -5% | -$16.3K | 0.01% | 896 |
|
2020
Q3 | $228K | Buy |
3,225
+1,045
| +48% | +$73.9K | 0.01% | 897 |
|
2020
Q2 | $140K | Sell |
2,180
-235
| -10% | -$15.1K | ﹤0.01% | 1005 |
|
2020
Q1 | $72K | Buy |
2,415
+915
| +61% | +$27.3K | ﹤0.01% | 1122 |
|
2019
Q4 | $29K | Hold |
1,500
| – | – | ﹤0.01% | 1639 |
|
2019
Q3 | $23K | Hold |
1,500
| – | – | ﹤0.01% | 1679 |
|
2019
Q2 | $21K | Buy |
+1,500
| New | +$21K | ﹤0.01% | 1690 |
|